Advanced Medical Optics, Inc. Enters into Phacoemulsification Patent Agreement with Bausch & Lomb

SANTA ANA, Calif.--(BUSINESS WIRE)--Advanced Medical Optics, Inc. (AMO) (NYSE:EYE), a global leader in ophthalmic medical devices and eye care products, today announced that it has entered into an agreement with Bausch & Lomb, Inc. regarding AMO’s U.S. Patent entitled “Fluid Management Systems with Vertex Chamber” (Patent No. 6,059,765) and its foreign counterparts, all of which relate to peristaltic pump fluidics used in phacoemulsification systems. Bausch & Lomb will pay AMO a royalty under the agreement. All other terms of the agreement are confidential.

MORE ON THIS TOPIC